Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 349641 - 349660 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L04AC05) ustekinumab (adm: P) | Uzpruvo 45 mg | 0.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 45 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | StadaArzneimittelAG |
| Norway | (L04AC05) ustekinumab (adm: P) | Imuldosa 90 mg | 1 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 90 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Psoriasis;Arthritis, Psoriatic | AccordHealthcareS.L.U. |
| Norway | (L04AC05) ustekinumab (adm: P) | Stelara 90 mg | 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 90 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. |
| Norway | (L04AC05) ustekinumab (adm: P) | Stelara 90 mg | 1 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 90 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. |
| Norway | (L04AC05) ustekinumab (adm: P) | Uzpruvo 90 mg | 1 ml, Ferdigfylt sprøyte, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 90 mg , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | StadaArzneimittelAG |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 1 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 1 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 1 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml | 1 x 20 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml | 1 x 10 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 20 mg/ml | 1 x 4 ml, Hetteglass, Infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 4 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 4 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 4 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg | 4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg | 4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC08) canakinumab (adm: P) | Ilaris 150 mg/ml | 1 ml, Hetteglass, Injeksjonsvæske, oppløsning, 150 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NovartisEuropharmLimited(1) |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLimited(1) |
Pages
